Viewing Study NCT02531932


Ignite Creation Date: 2025-12-24 @ 9:39 PM
Ignite Modification Date: 2026-02-20 @ 4:46 PM
Study NCT ID: NCT02531932
Status: COMPLETED
Last Update Posted: 2025-02-19
First Post: 2015-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
Sponsor: Amy Tiersten
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced triple negative breast cancer View